Compounds > acetylcysteine

acetylcysteine and Heart Failure, Systolic

acetylcysteine has been researched along with Heart Failure, Systolic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Khansari, N; Mehrpooya, M; Mohammadi, Y; Yazdi, A; Zareie, S1
Betocchi, S; Chen, J; Chen, SN; Efimov, IR; Li, W; Lombardi, R; Marian, AJ; Ripplinger, CM; Rodriguez, G; Wickline, SA; Willerson, JT1

Other Studies

2 other study(ies) available for acetylcysteine and Heart Failure, Systolic

ArticleYear
Oral N-acetylcysteine as an adjunct to standard medical therapy improved heart function in cases with stable class II and III systolic heart failure.
    Irish journal of medical science, 2022, Volume: 191, Issue:5

    Topics: Acetylcysteine; Heart Failure; Heart Failure, Systolic; Humans; Iran; Stroke Volume; Ventricular Function, Left; Ventricular Function, Right

2022
Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms.
    Circulation, 2009, Mar-17, Volume: 119, Issue:10

    Topics: Acetylcysteine; Actins; Animals; Animals, Genetically Modified; Antioxidants; Cardiomyopathy, Hypertrophic; Cell Size; Disease Models, Animal; Female; Fibrosis; Glutathione; Heart Failure, Systolic; Humans; Male; MAP Kinase Signaling System; Myocytes, Cardiac; Myosin Heavy Chains; NFATC Transcription Factors; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Processing, Post-Translational; Rabbits; Sulfhydryl Compounds; Ventricular Fibrillation

2009